ArticleThe oncologist2016

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.

Khurum H Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.